EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-SA 4.0

PATIENT WITH PRIMARY OVARIAN FAILURE DUE TO INTERMEDIATE PREMUTATION OF THE FMR1 GENE USING TRANSDERMAL TESTOSTERONE IN IVF TREATMENT, CASE REPORT AND LITERATURE REVIEW

Fernando Mancilla Hernández, Jorge L. Lezama Ruvalcaba, Ricardo Rodríguez Calderón, Carlos G. Salazar López-Ortiz, Paola R. Becerril Rodríguez, Julio C. Rodríguez Verduzco

Journal of IVF-Worldwide · 2024

DOI: 10.46989/001c.117352 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of IVF-Worldwide, 2024. Verfasst von Fernando Mancilla Hernández und 5 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fragile X syndrome (FXS) is a condition of non-Mendelian nucleotide repeats, which is due to the loss of function of the FMR1 gene (Fragile X Mental Retardation 1); it is caused by the hypermethylation of the repetitions of CGG (cytosine-guanine-guanine triple), expanded adjacent to exon 1 of the FMR1 gene; this mutation affects more than 98% of people with SXF. Clinical Case 35-year-old patient. Consulted for primary infertility of 1 year of evolution, relevant biochemical studies were requested, among which he highlighted the result of Anti-Mullerian Hormone of 0.40 ng/mL. By age and diagnosis of low ovarian reserve, it is decided to perform FMR1 mutation analysis in search of the cause of the probable primary ovarian failure, resulting in a premutation with repetition of 49 CGG. It is decided to perform a cycle of controlled ovarian stimulation, with menotropins 300 IU every 24 hours + dydrogesterone 30mg orally to inhibit LH peak, as well as the use of transdermal testosterone 50 mg every 24 hours to improve the ovarian response, obtaining 2 MII oocytes, which are vitrified. It is decided to perform a 2nd cycle of ovarian stimulation with menotropins 300 Units + GnRH antagonist to be able to make embryo transfer. The use of 50mg of transdermal testosterone to improve the result, obtaining 4MII, a total of 6 MII oocytes for the two cycles, ICSI (intracytoplasmic sperm injection) is performed at the 6 oocytes of which 4 embryos were obtained in the blastocyst stage, transferring 1 embryo in fresh, and vitrifying 3, quantification of hCG beta-positive fraction is performed at 10 days post-transfer, obtaining a live newborn, male with a weight of 4,010 kg, Size: 58 cm without complications.

Conclusions

FMR1 premutation is associated with a risk of reduced ovarian function and premature ovarian failure with the early loss of fertility in 20% of carrier women due to the reduced number of follicles in the ovaries. Transdermal pretreatment of testosterone seems to increase pregnancy and the rates of live births in people considered deficient who undergo ovarian stimulation for IVF.

Zitieren

APA

Hernández, F. M., Ruvalcaba, J. L. L., Calderón, R. R., López-Ortiz, C. G. S., Rodríguez, P. R. B., & Verduzco, J. C. R. (2024). PATIENT WITH PRIMARY OVARIAN FAILURE DUE TO INTERMEDIATE PREMUTATION OF THE FMR1 GENE USING TRANSDERMAL TESTOSTERONE IN IVF TREATMENT, CASE REPORT AND LITERATURE REVIEW. Journal of IVF-Worldwide. https://doi.org/10.46989/001c.117352

Vancouver

Hernández FM, Ruvalcaba JLL, Calderón RR, López-Ortiz CGS, Rodríguez PRB, Verduzco JCR. PATIENT WITH PRIMARY OVARIAN FAILURE DUE TO INTERMEDIATE PREMUTATION OF THE FMR1 GENE USING TRANSDERMAL TESTOSTERONE IN IVF TREATMENT, CASE REPORT AND LITERATURE REVIEW. Journal of IVF-Worldwide. 2024. doi:10.46989/001c.117352

BibTeX
@article{Hernndez2024,
  author = {Hernández, Fernando Mancilla and Ruvalcaba, Jorge L. Lezama and Calderón, Ricardo Rodríguez and López-Ortiz, Carlos G. Salazar and Rodríguez, Paola R. Becerril and Verduzco, Julio C. Rodríguez},
  title = {PATIENT WITH PRIMARY OVARIAN FAILURE DUE TO INTERMEDIATE PREMUTATION OF THE FMR1 GENE USING TRANSDERMAL TESTOSTERONE IN IVF TREATMENT, CASE REPORT AND LITERATURE REVIEW},
  journal = {Journal of IVF-Worldwide},
  year = {2024},
  doi = {10.46989/001c.117352}
}
Kostenlos starten →